We offer a comprehensive panel of investigational tests that can diagnose, subgroup and prognosticate the type of Leukaemia with high accuracy. The purpose of these tests is to allow us to fully understand the biology of the Leukaemia in each individual patient, so as to effectively track the treatment response and accurately tailor our treatment to optimise the response.
At the NCIS, risk profiles of children diagnosed with childhood leukaemia are studied, allowing us to predict the risk of them developing leukaemia, their chances of cure, as well as complications from therapy in order to maximise clinical outcomes. This is funded by the National Medical Research Council, Children's Cancer Foundation and Viva Foundation for Children with Cancer.
